Apoptosis: an early event in metastatic inefficiency.

Whereas large numbers of cells from a primary tumor may gain access to the circulation, few of them will give rise to metastases. The mechanism of elimination of these tumor cells, often termed "metastatic inefficiency," is poorly understood. In this study, we show that apoptosis in the lungs within 1-2 days of introduction of the cells is an important component of metastatic inefficiency. First, we show that death of transformed, metastatic rat embryo cells occurred via apoptosis in the lungs 24-48 h after injection into the circulation. Second, we show that Bcl-2 overexpression in these cells inhibited apoptosis in culture and also conferred resistance to apoptosis in vivo in the lungs 24-48 h after injection. This inhibition of apoptosis led to significantly more macroscopic metastases. Third, comparison between the extent of apoptosis by a poorly metastatic cell line to that by a highly metastatic cell line 24 h after injection in the lungs revealed more apoptosis by the poorly metastatic cell line. These results indicate that apoptosis, which occurs at 24-48 h after hematogenous dissemination in the lungs is an important determinant of metastatic inefficiency. Although prior work has shown an association between apoptosis in culture and metastasis in vivo, this work shows that apoptosis in vivo corresponds to decreased metastasis in vivo.

[1]  G. Nicolson,et al.  Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma. , 1978, Israel journal of medical sciences.

[2]  R. Muschel,et al.  Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. , 1996, Cancer research.

[3]  F. Orr,et al.  Promotion of pulmonary metastasis in mice by bleomycin-induced endothelial injury. , 1986, Cancer research.

[4]  D. McConkey,et al.  Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. , 1996, Cancer research.

[5]  H. Sambrook Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[6]  I. Fidler,et al.  Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. , 1995, Cancer research.

[7]  U. Bagge,et al.  Lethal deformation of cancer cells in the microcirculation: A potential rate regulator of hematogenous metastasis , 1992, International journal of cancer.

[8]  C. Stackpole Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis. , 1983, Cancer research.

[9]  K. Luzzi,et al.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.

[10]  W. Yu,et al.  Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay , 1998, Cell.

[11]  Z. Werb,et al.  Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Liotta,et al.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.

[13]  J. Lundy,et al.  In vitro and in vivo adherence of tumor cell variants correlated with tumor formation. , 1980, The American journal of pathology.

[14]  R. Muschel,et al.  The effect of E1A transfection on MMP‐9 expression and metastatic potential , 1995, International journal of cancer.

[15]  K. Kinzler,et al.  Paradoxical inhibition of solid tumor cell growth by bcl2. , 1994, Cancer research.

[16]  J. Uhr,et al.  Flow cytometry--principles and feasibility in transfusion medicine. Enumeration of epithelial derived tumor cells in peripheral blood. , 1998, Vox sanguinis.

[17]  P. Stroeken,et al.  Targeted disruption of the beta1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity. , 1998, Cancer research.

[18]  John Calvin Reed,et al.  Anti-cell death activity promotes pulmonary metastasis of melanoma cells , 1997, Oncogene.

[19]  K. Pantel Detection of minimal disease in patients with solid tumors. , 1996, Journal of hematotherapy.

[20]  E. Ruoslahti,et al.  Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.

[21]  J. Uhr,et al.  Flowcytometry ‐ Principles and Feasibility in Transfusion Medicine. Enumeration of Epithelial Derived Tumor Cells in Peripheral Blood , 1998 .

[22]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[23]  L. Weiss,et al.  Metastatic inefficiency. , 1990, Advances in cancer research.

[24]  B. Pauli,et al.  Blocking of lung endothelial cell adhesion molecule-1 (Lu-ECAM-1) inhibits murine melanoma lung metastasis. , 1992, The Journal of clinical investigation.

[25]  I. Macdonald,et al.  Sequential steps in hematogenous metastasis of cancer cells studied by in vivo videomicroscopy. , 1997, Invasion & metastasis.

[26]  I. Fidler,et al.  Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .

[27]  A. Al-Mehdi,et al.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.

[28]  J. Segall,et al.  Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. , 1998, Cancer research.

[29]  S. Polak‐Charcon,et al.  DAP kinase links the control of apoptosis to metastasis , 1997, Nature.

[30]  E Ruoslahti,et al.  Integrins and anoikis. , 1997, Current opinion in cell biology.

[31]  J. Widom,et al.  Cloning and Characterization of Lung-Endothelial Cell Adhesion Molecule-1 Suggest It Is an Endothelial Chloride Channel* , 1997, The Journal of Biological Chemistry.

[32]  K. Hofer,et al.  Ga-citrate and I-iododeoxyuridine as markers for in vivo evaluation of tumor cell metastasis and death. , 1973, Journal of the National Cancer Institute.

[33]  R. Muschel,et al.  Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. , 1990, Cancer research.

[34]  C. Leonetti,et al.  Bcl‐2 overexpression enhances the metastatic potential of a human breast cancer line , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  A. Kimchi,et al.  Dap-Kinase Participates in TNF-α–And FAS-Induced Apoptosis and Its Function Requires the Death Domain , 1999, The Journal of cell biology.

[36]  Z. Werb,et al.  Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix , 1995, Science.

[37]  R. Elble,et al.  Lung Endothelial Dipeptidyl Peptidase IV Promotes Adhesion and Metastasis of Rat Breast Cancer Cells via Tumor Cell Surface-associated Fibronectin* , 1998, The Journal of Biological Chemistry.

[38]  L. Shaw,et al.  The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice. , 1997, The American journal of pathology.

[39]  R. Muschel,et al.  Site-specific integration of H-ras in transformed rat embryo cells. , 1988, Science.

[40]  R. C. Johnson,et al.  Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells , 1993, The Journal of cell biology.

[41]  R. Pozzatti,et al.  The E1a gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells , 1988, Molecular and cellular biology.

[42]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[43]  C. Stackpole Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma , 1981, Nature.

[44]  G. Nicolson,et al.  Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. , 1976, Journal of the National Cancer Institute.

[45]  R. Elble,et al.  Lu-ECAM-1 and DPP IV in lung metastasis. , 1996, Current topics in microbiology and immunology.

[46]  J. Rak,et al.  Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis , 1991, International journal of cancer.

[47]  L. Liotta,et al.  In vivo monitoring of the death rate of artificial murine pulmonary micrometastases. , 1978, Cancer research.

[48]  I. Stamenkovic,et al.  Induction of Apoptosis of Metastatic Mammary Carcinoma Cells In Vivo by Disruption of Tumor Cell Surface CD44 Function , 1997, The Journal of experimental medicine.

[49]  A. Kimchi,et al.  Isolation of DAP3, a Novel Mediator of Interferon-γ-induced Cell Death (*) , 1995, The Journal of Biological Chemistry.

[50]  S. Gruber,et al.  Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[51]  L. Weiss,et al.  The differential resistance of B16 wild-type and F10 cells to mechanical trauma in vitro. , 1993, Invasion & metastasis.

[52]  L. Owen-Schaub,et al.  Fas and Fas Ligand Interactions Suppress Melanoma Lung Metastasis , 1998, The Journal of experimental medicine.

[53]  A. Weiss,et al.  Detection and characterization of carcinoma cells in the blood. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  G. Nicolson,et al.  Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipients. , 1977, Journal of the National Cancer Institute.

[55]  K P Dingemans,et al.  Mechanisms of metastasis. , 1979, Biochimica et biophysica acta.

[56]  S. Lowe,et al.  Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependence , 1997, Oncogene.

[57]  I. Macdonald,et al.  Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. , 2000, Cancer research.

[58]  J. McGhee,et al.  ELT-3: A Caenorhabditis elegans GATA factor expressed in the embryonic epidermis during morphogenesis. , 1999, Developmental biology.